Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC17157Cevimeline hydrochloride hemihydrateCAS: 153504-70-2纯度: >98.00%
Cevimeline hydrochloride hemihydrate (SNI-2011) 是乙酰胆碱的奎宁环衍生物,是一种选择性和口服活性的毒蕈碱 M1 和 M3 受体激动剂。
- GC17162MK-5108 (VX-689)CAS: 1010085-13-8纯度: >98.00%
MK-5108 (VX-689)是一种有效的ATP竞争性Aurora A激酶抑制剂,IC 50 值为0.064nM。
- GC17182Solifenacin succinateCAS: 242478-38-2纯度: >99.00%
A muscarinic M 1 , M 2 , and M 3 receptor antagonist
- GC17203Varespladib (LY315920)CAS: 172732-68-2纯度: >98.50% / >98.00%
Varespladib (LY315920)是一种强效、选择性的group IIA, nonpancreatic secretory PLA2 (sPLA2)抑制剂,IC 50 值为9nM。
- GC17214PF-3758309CAS: 898044-15-0纯度: >98.50%
PF-3758309是 ATP竞争性p21活化激酶4(PAK4)抑制剂,其Kd值为2.7nM,Ki值为18.7nM。
- GC172182-fluoro Palmitic AcidCAS: 16518-94-8纯度: >98.00%
Inhibitor of sphingosine biosynthesis and long-chain acyl-CoA synthetase
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC17149 | 4-CMTB | 300851-67-6 | >99.00% | |
4-CMTB是一种选择性的游离脂肪酸受体2(FFA2/GPR43)激动剂和正变构调节剂。 | ||||
| GC17152 | Dofetilide | 115256-11-6 | >98.00% | |
An antiarrythmic agent that inhibits potassium channels | ||||
| GC17153 | CHIR-99021 (CT99021) HCl | 1797989-42-4 | >99.50% | |
A selective GSK3 inhibitor | ||||
| GC17157 | Cevimeline hydrochloride hemihydrate | 153504-70-2 | >98.00% | |
Cevimeline hydrochloride hemihydrate (SNI-2011) 是乙酰胆碱的奎宁环衍生物,是一种选择性和口服活性的毒蕈碱 M1 和 M3 受体激动剂。 | ||||
| GC17158 | IRAK inhibitor 1 | 1042224-63-4 | >99.00% | |
An IRAK4 inhibitor | ||||
| GC17162 | MK-5108 (VX-689) | 1010085-13-8 | >98.00% | |
MK-5108 (VX-689)是一种有效的ATP竞争性Aurora A激酶抑制剂,IC 50 值为0.064nM。 | ||||
| GC17163 | Elacridar hydrochloride | 143851-98-3 | >98.00% | |
An inhibitor of MRP-1 and BCRP | ||||
| GC17173 | Felodipine | 72509-76-3 | >98.50% | |
An L-type calcium channel inhibitor | ||||
| GC17176 | Ethambutol | 74-55-5 | - | |
An antimycobacterial compound | ||||
| GC17178 | TCS PIM-1 1 | 491871-58-0 | >98.00% | |
A Pim-1 kinase inhibitor | ||||
| GC17182 | Solifenacin succinate | 242478-38-2 | >99.00% | |
A muscarinic M 1 , M 2 , and M 3 receptor antagonist | ||||
| GC17183 | CP-809101 | 479683-64-2 | - | |
A potent 5-HT 2C receptor agonist | ||||
| GC17184 | Ambrisentan | 177036-94-1 | >99.50% | |
Ambrisentan是一种口服活性、高选择性的内皮素受体ETA的选择性拮抗剂,IC 50 值为0.6nM。 | ||||
| GC17187 | LY2090314 | 603288-22-8 | >99.00% | |
A potent and selective inhibitor of GSK3 | ||||
| GC17193 | MOG (35-55) | 149635-73-4 | - | |
MOG (35-55)是髓磷脂少突胶质细胞糖蛋白的35-55片段。 | ||||
| GC17196 | Hesperadin | 422513-13-1 | >98.00% | |
Hesperadin是一种竞争性ATP结合抑制剂,对Aurora B激酶的IC 50 为250nM。 | ||||
| GC17197 | Detomidine | 76631-46-4 | - | |
Detomidine 是一种咪唑衍生物,是一种有效的 α2-肾上腺素能激动剂。 | ||||
| GC17200 | Nestoron | 7759-35-5 | >99.50% | |
A synthetic progestin | ||||
| GC17203 | Varespladib (LY315920) | 172732-68-2 | >98.50% / >98.00% | |
Varespladib (LY315920)是一种强效、选择性的group IIA, nonpancreatic secretory PLA2 (sPLA2)抑制剂,IC 50 值为9nM。 | ||||
| GC17205 | CP-945598 HCl | 686347-12-6 | - | |
A selective CB 1 receptor antagonist | ||||
| GC17212 | A 438079 | 899507-36-9 | >99.50% | |
A 438079是一种高选择性P2X7受体(P2X7R)拮抗剂,对大鼠P2X7R的IC 50 值为0.1μM。 | ||||
| GC17214 | PF-3758309 | 898044-15-0 | >98.50% | |
PF-3758309是 ATP竞争性p21活化激酶4(PAK4)抑制剂,其Kd值为2.7nM,Ki值为18.7nM。 | ||||
| GC17215 | Elacridar | 143664-11-3 | >98.00% | |
An inhibitor of MRP-1 and BCRP | ||||
| GC17218 | 2-fluoro Palmitic Acid | 16518-94-8 | >98.00% | |
Inhibitor of sphingosine biosynthesis and long-chain acyl-CoA synthetase | ||||
